Vaccinating people living with HIV: a fast track to preventive and therapeutic HIV vaccines
- 23 October 2023
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 24 (4) , e252-e255
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Clinical trials of antiretroviral treatment interruption in HIV-infected individualsAIDS, 2019
- Combination therapy with anti-HIV-1 antibodies maintains viral suppressionNature, 2018
- Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer ImmunizationImmunity, 2018
- Determinants of HIV-1 broadly neutralizing antibody inductionNature Medicine, 2016
- Cohort Profile: Antiretroviral Therapy Cohort Collaboration (ART-CC)International Journal of Epidemiology, 2013
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialNew England Journal of Medicine, 2012
- The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4 + T Cell Decline and High Viral Load during Acute InfectionJournal of Virology, 2011
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- In Vivo Efficacy of Human Immunodeficiency Virus Neutralizing Antibodies: Estimates for Protective TitersJournal of Virology, 2008
- Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodiesNature Medicine, 2005